Cervical cancer is a treatable disease, yet over 4,000 American women are still dying from it each year. Pap smear tests, which detect signs of cervical cancer and enable early treatment, have been outsourced to national, for-profit lab companies. More concerned with profit than public health, these companies are taking shortcuts that put the lives of American women at stake.
Cervical cancer is a slow-developing disease; typically, eight years pass between the first signs of cervical cancer and an advanced stage of the disease. Pap smears can detect precancerous or abnormal cervical cells long before they develop into active cancer. Women who follow recommended guidelines for pap testing, which provide for testing every 1 - 5 years, depending on the patientâ€™s medical history, should always have ample time to treat the disease before it spreads. Recent reports show that misread pap smear tests are on the rise, resulting in cervical cancer misdiagnosis. In simple terms, women who are doing everything in their power to protect their health are dying of cervical cancer â€“ a preventable disease â€“ and companies are profiting.
Women and the family members of women who have been diagnosed with cervical cancer with no prior history of an abnormal pap smear may be entitled to real compensation for suffering, pain, and loss through filing a cervical cancer misdiagnosis lawsuit against for-profit lab companies. Any time a company is suspected of profiting at the expense of consumer safety, our firm is dedicated to achieving justice. Filing a misread pap smear lawsuit will serve to exert pressure on the company to become a better corporate citizen, in addition to seeking the compensation you family deserves.
Pap smears are simple tests that involve obtaining a sample of cervical cells during a routine pelvic exam, then viewing the cells under a microscope to assess whether any appear to be abnormal. When atypical cells are discovered, further testing is often required to determine whether the cells are indicative of cervical cancer or precancerous growth. Pap smears allow providers to find abnormal cells early, and use relatively non-invasive methods to rid the body of harm long before cancer has developed or the patientâ€™s life is at stake.
Traditionally, pap smear slides were viewed manually by the gynecologistâ€™s in-house lab. If any slides were in question, the doctor would be able to view the slides personally. In other words, the responsibility for both collecting and reviewing the sample fell to the same team of providers. When pap smear testing was first widely adopted, the practice accounted for significant improvements in cervical cancer outcomes.
Today, most pap smear slides are sent off-site to a for-profit laboratory not connected with the provider. These companies employ lab technicians whose sole job is to review slides. Automations, designed to increase efficiency, use computer programming to auto-select portions of the slide for the technician to review. Disconnected from the provider, these technicians are focused more on maximum output than on accuracy. Churning through up to 150 slides in a single day, these technicians are increasingly making mistakes and missing early signs of cervical cancer. Because they are handled offsite, often in another state, doctors themselves are unable to view the slides for confirmation.
Misread pap smears are being blamed for an increased rates of cervical cancer misdiagnosis. When irregular or cancerous cells are detected early, cervical cancer can be easily treated with very little trouble for the patient. When the diagnosis of cervical cancer is delayed, the slow-advancing disease is allowed to grow and spread for years before noticed. As a result, women are dying from disease that we have the tools to detect and treat early. This is an unthinkable tragedy, and women and the families of women suffering from advanced cervical cancer are rightly outraged.
If you or a woman in your family has been diagnosed with an active or advanced stage of cervical cancer with no prior indication of an abnormal pap smear result, you may have grounds to file a claim for delayed cervical cancer diagnosis. Our attorneys handling pap smear lawsuits believe women who meet this description may be eligible for real compensation for the pain, suffering, and medical bills resulting from misdiagnosis of cervical cancer.
When American families suffer as a result of corporate negligence and greed, our attorneys see it as their duty to pursue justice, no matter how complex the case. Through settlements and winning verdicts, our attorneys have obtained millions on behalf of clients harmed by dangerous drugs. Let us help you today.
Critics say pap smear analysis focuses more on efficiency than accuracy, due to the â€œoutsourcingâ€ of pap smear test processing to private, for-profit national corporations. Pressured to analyze pap smear slide efficiently, lab technicians are producing false negatives, resulting in the misdiagnosis of cervical cancer and delayed treatment. Our cervical cancer lawyers believe persons who were harmed by misread pap smears may be eligible for real compensation by filing a claim against the for-profit lab companies.
Our experienced pap smear lawyers have seen the aftereffects of numerous drug recalls. Aware of the very serious nature of cervical cancer lawsuit claims, this national* drug litigation law firm has committed significant resources to ensuring the best pap smear attorney representation possible. These cervical cancer misdiagnosis lawyers will provide a free case review to women and family members of women who diagnosed with cervical cancer with no prior history of an abnormal pap smear. Millions of patients have unknowingly put their lives in the hands of private lab companies whose prime motivation is profit. Truvada attorneys endeavor to win needed compensation for those who have been harmed, while simultaneously holding these private lab corporations accountable for risking public health.
We will represent all persons involved in a pap smear lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Women and family members of women who have been diagnosed with active or advanced cervical cancer with no prior abnormal pap smear history qualify for a free, no-obligation case review from our cervical cancer attorneys. Use the chat feature or complete the online contact form to speak with an experienced misread pap smear lawyer about your case.
Our attorneys have experience in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.
Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.
Essure is a contraceptive approved by the FDA as a form of permanent birth control. The complications associated with Essure have become so severe that its maker is halting all sales outside of the US. Essure complications include ectopic pregnancy, migration & expulsion, perforation or tear of pelvic organs including the uterus and colon. Many of the Essure complications require one or more surgeries, including hysterectomy, to remove it and repair internal organs.
Roundup weed killer, manufactured by Monsanto, uses a chemical called glyphosate, which the World Health Organization labeled as a probable carcinogen in 2015. Roundup is the most popular of all glyphosate-based herbicides. As little as 8 hours of Roundup exposure has been linked to an increased risk of non-Hodgkin lymphoma, multiple myeloma, and leukemia. Millions of gardeners, landscapers, farmers and others have been exposed to Roundup cancer risks.
Taxotere is a chemotherapy drug that has been widely used over the last two decades, for treating breast cancer among others. Although hair loss is a side effect of many chemotherapy treatments, hair loss for many Taxotere users is permanent. For some Taxotere users, the permanent hair loss is complete, other users have clumps of hair regrowth. Some people will regrow some or all of their hair after a number of years, others never regrow hair.